Corrigendum to "Efficacy and safety of biologics targeting IL-17 and IL-23 in the treatment of moderate-to-severe plaque psoriasis: A systematic review and meta-analysis of randomized controlled trials" [Int. Immunopharmacol. 62 (2018) 46-58]
Int Immunopharmacol. 2018 Nov:64:432.
doi: 10.1016/j.intimp.2018.08.039.
Epub 2018 Sep 13.
1 Department of Dermatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
2 Department of Dermatology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. Electronic address: shiyuling1973@tongji.edu.cn.